Liontown Resources Ltd (ASX: LTR) and Mesoblast Ltd (ASX: MSB) are two of four ASX shares falling on Friday. Here's ...

Top 2024 performers include multiple health care stocks with unique catalysts, as well as several quantum computing ...

S&P/ASX All Ords Index (ASX: XAO) shares closed higher on the first day of trading for 2025, with these stocks clocking new ...

New data shows the 40 key ASX biotechs gained an average 50% in 2024 - but not all of them joined the winner's circle.

Mesoblast's FDA approval for remestemcel marks a milestone for MSC therapies, but limited cash reserves pose risks for US ...

INR:0580. blackjack en ligne gratuity The National Health Commission issued a document: Grassroots doctors with a secondary technical school degree or ...

INR:1697. rummy mind Anti-inflammatory cell therapy Ryoncil was approved by the US FDA expert panel with a high vote! China's first! Legend Biotech's CAR-T therapy is ...

INR:0064. karnataka cricket team vs rajasthan cricket team match scorecard Anti-inflammatory cell therapy Ryoncil ...

Amigo Fruits 5 uses in hindi Anti-inflammatory cell therapy Ryoncil was approved by the US FDA expert panel with a high vote! Osimertinib r ...

The allogeneic bone marrow-derived mesenchymal stromal cell (MSC) therapy Ryoncil (remestemcel-L-rknd) has been approved for ...

The Australian sharemarket has extended a late end of year rally, sidestepping a tech selloff in the US overnight as volumes ...

The Food and Drug Administration (FDA) has approved Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft vs host disease (SR-aGvHD) in pediatric patients 2 months of age ...